Headquartered in Germantown, Tennessee, McNeill Hotel Company is built on a foundation of trust, pursuit of excellence and making a difference in whatever we do. We espouse the philosophy of “people serving people” – be it our guests, our investors, our team members or our brand partners. Servant leadership truly defines our company culture. We focus on select service hotels with a growth strategy based on a mix of new hotel development, meaningful acquisitions and third-party management agreements. We are approved franchisees for Marriott, Hilton, and Hyatt. For updated News & Press about our company: http://www.mcneillhotels.com/news.php Visit our Glassdoor Page: https://www.glassdoor.com/Reviews/McNeill-Hotel-Company-Reviews-E1289810.htm

About Anju Anju is a customer-first organization providing adaptable life science solutions for clinical research, medical affairs, and data science. TrialMaster, IRMS MAX, and TA Scan, the company’s flagship products, reduce complexities in the drug and device discovery and commercialization process allowing our customers to enhance the quality of their patients’ lives. Customer First Our mission is to always be a customer-first organization, powered by a passionate team, providing best-value life science solutions paired with an excellent customer experience to simplify the complexities of life science information management. Driving Impactful Results Anju solutions are used by large, mid-sized, and small pharmaceutical companies, clinical research organizations (CROs), and medical device companies as well as full-service medical marketing, market research, and communications agencies. Our technologies facilitate data flow between our solutions and seamless communication with third-party systems, providing a unique opportunity for our customers to leverage critical information and drive impactful results. Experienced Leadership Anju is a portfolio company of Abry Partners, which is one of the most experienced and successful sector-focused private equity investment firms in North America. Since their founding in 1989, the firm has completed over $90 billion of leveraged transactions and other private equity or preferred equity placements. Currently, the firm manages over $5 billion of capital across their active funds.